---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-056027"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T23:00:23.602254+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# PowerUp Acquisition trust balance stands at $303.3M ($10.55/share) as of May 3, 2023

## Summary
- Trust account held at Citibank with American Stock Transfer as trustee; balance $303,324,683.
- Per-share trust value of $10.55 for public shares, updated ahead of extension vote.
- Company filed Definitive Proxy Statement on April 21, 2023 for Extension Amendment Proposal.
- Proceeds from IPO remain in trust pending potential business combination or extension.

## SEC filing metadata
- accession: 0001104659-23-056027
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000110465923056027/0001104659-23-056027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000110465923056027/tm2314762d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-056027
- JSON: https://secwatch.observer/filing/0001104659-23-056027.json
- Plain text: https://secwatch.observer/filing/0001104659-23-056027.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.